Table 2

Microbiological analyses

Bacterial*Total population n=488Not hospitalised (n=432)Hospitalised (n=56)
Streptococcus pneumoniae n (%)4/494 (0.8%)4/438 (0.9%)0/56 (0 %)NS
Staphylococcus aureus n (%)2/494 (0.4%)2/438 (0.5%)0/56 (0%)NS
Haemophilus spp. n (%)2/494 (0.4%)2/438 (0.5%)0/56 (0%)NS
Mycoplasma pneumoniae n (%)3/494 (0.6%)3/438 (0.7%)0/56 (0%)NS
Chlamydia pneumoniae (%)2/494 (0.4%)2/438 (0.5%)0/56 (0%)NS
Any bacterial infection n (%)13/494 (2.6%)13/438 (3.0%)0/56 (0%)NS
Viral†
 Adenovirus n (%)82/494 (16.6%)71/438 (16.2%)11/56 (19.6%)NS
 Bocavirus n (%)100/494 (20.2%)92/438 (21%)8/56 (20.5%)NS
 CoV HKU n (%)0/494 (0%)0/438 (0%)0/56 (0%)NS
 CoV NL63 n (%)1/494 (0.2%)1/438 (0.2%)0/56 (0%)NS
 CoV 229E n (%)1/494 (0.2%)1/438 (0.2%)0/56 (0%)NS
 CoV OC43 n (%)1/494 (0.2%)1/438 (0.2%)0/56 (0%)NS
 Influenza A n (%)76/494 (15.4%)74/438 (16.9%)2/56 (15.6%)NS
 Influenza AH1 n (%)64/494 (13%)63/438 (14.4%)1/56 (1.8%)0.001
 Influenza AH3 n (%)6/494 (1.2%)6/438 (1.4%)0/56 (0%)NS
 Influenza B n (%)9/494 (1.8%)8/438 (1.8%)1/56 (1.8%)NS
 HMPV n (%)73/494 (14.7%)63/438 (14.4%)10/56 (15.0%)NS
 Parainfluenza 1 n (%)11/494 (2.2%)10/438 (2.3%)1/56 (1.8%)NS
 Parainfluenza 2 n (%)10/494 (2.0%)10/438 (2.3%)0/56 (0%)NS
 Parainfluenza 3 n (%)4/494 (0.8%)3/438 (0.7%)1/56 (1.8%)NS
 Parainfluenza 4 n (%)17/494 (3.4%)15/438 (3.4%)2/56 (3.6%)NS
 RSV A n (%)164/494 (33.2%)144/438 (32.9%)20/56 (35.7%)NS
 RSV B n (%)50/488 (10.1%)44/438 (10%)6/56 (10.7%)NS
 Rhino/enterovirus n (%)295/494 (59.7%)263/438 (60%)32/56 (57.1%)NS
 Any virus n (%)940/488448/494 (93.1%)409/432 (94.7%)51/56 (91.1%)NS
  • *Two other bacterial species were identified in the patients who were not hospitalised, but were not clinically associated with pneumonia (Escherichia coli and Shigella).

  • †In six cases, it was not possible to obtain a valid PCR run.

  • CoV, coronavirus; HMPV, Human Metapneumovirus; NS, not significant; RSV, Respiratory Synctial Virus.